These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 27341798

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model.
    Luo J, Dong B, Wang K, Cai S, Liu T, Cheng X, Lei D, Chen Y, Li Y, Kong J, Chen Y.
    PLoS One; 2017; 12(4):e0176883. PubMed ID: 28453568
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sub-minimum inhibitory concentrations of ceftazidime inhibit Pseudomonas aeruginosa biofilm formation.
    Otani S, Hiramatsu K, Hashinaga K, Komiya K, Umeki K, Kishi K, Kadota JI.
    J Infect Chemother; 2018 Jun; 24(6):428-433. PubMed ID: 29449129
    [Abstract] [Full Text] [Related]

  • 5. Clarithromycin destroys biofilms and enhances bactericidal agents in the treatment of Pseudomonas aeruginosa osteomyelitis.
    Kandemir O, Oztuna V, Milcan A, Bayramoğlu A, Celik HH, Bayarslan C, Kaya A.
    Clin Orthop Relat Res; 2005 Jan; (430):171-5. PubMed ID: 15662320
    [Abstract] [Full Text] [Related]

  • 6. Effect of the combination of clarithromycin and amikacin on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection.
    Cirioni O, Ghiselli R, Silvestri C, Minardi D, Gabrielli E, Orlando F, Rimini M, Brescini L, Muzzonigro G, Guerrieri M, Giacometti A.
    J Antimicrob Chemother; 2011 Jun; 66(6):1318-23. PubMed ID: 21406436
    [Abstract] [Full Text] [Related]

  • 7. In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients.
    Fernández-Olmos A, García-Castillo M, Maiz L, Lamas A, Baquero F, Cantón R.
    Int J Antimicrob Agents; 2012 Aug; 40(2):173-6. PubMed ID: 22727530
    [Abstract] [Full Text] [Related]

  • 8. In vitro pharmacokinetics/pharmacodynamics of continuous ceftazidime infusion alone and in combination with colistin against Pseudomonas aeruginosa biofilm.
    Gómez-Junyent J, Murillo O, Yu HH, Azad MAK, Wickremasinghe H, Rigo-Bonnin R, Benavent E, Ariza J, Li J.
    Int J Antimicrob Agents; 2021 Feb; 57(2):106246. PubMed ID: 33253904
    [Abstract] [Full Text] [Related]

  • 9. Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides.
    Dosler S, Karaaslan E.
    Peptides; 2014 Dec; 62():32-7. PubMed ID: 25285879
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
    Benthall G, Touzel RE, Hind CK, Titball RW, Sutton JM, Thomas RJ, Wand ME.
    Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845
    [Abstract] [Full Text] [Related]

  • 13. In-vitro evaluation of a ciprofloxacin and azithromycin sinus stent for Pseudomonas aeruginosa biofilms.
    Lim DJ, Skinner D, Mclemore J, Rivers N, Elder JB, Allen M, Koch C, West J, Zhang S, Thompson HM, McCormick JP, Grayson JW, Cho DY, Woodworth BA.
    Int Forum Allergy Rhinol; 2020 Jan; 10(1):121-127. PubMed ID: 31692289
    [Abstract] [Full Text] [Related]

  • 14. Ceftazidime, gentamicin, and rifampicin, in combination, kill biofilms of mucoid Pseudomonas aeruginosa.
    Ghani M, Soothill JS.
    Can J Microbiol; 1997 Nov; 43(11):999-1004. PubMed ID: 9436304
    [Abstract] [Full Text] [Related]

  • 15. Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1.
    Riera E, Macià MD, Mena A, Mulet X, Pérez JL, Ge Y, Oliver A.
    J Antimicrob Chemother; 2010 Jul; 65(7):1399-404. PubMed ID: 20435779
    [Abstract] [Full Text] [Related]

  • 16. Using host-mimicking conditions and a murine cutaneous abscess model to identify synergistic antibiotic combinations effective against Pseudomonas aeruginosa.
    Lyons N, Wu W, Jin Y, Lamont IL, Pletzer D.
    Front Cell Infect Microbiol; 2024 Jul; 14():1352339. PubMed ID: 38808066
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of Combined Ciprofloxacin and azithromycin free and nano formulations to control biofilm producing Pseudomonas aeruginosa isolated from burn wounds.
    Raouf M, Essa S, El Achy S, Essawy M, Rafik S, Baddour M.
    Indian J Med Microbiol; 2021 Jan; 39(1):81-87. PubMed ID: 33460732
    [Abstract] [Full Text] [Related]

  • 18. In vitro efficacy of various antibiotic combinations against Pseudomonas aeruginosa isolates.
    Nazli E, Zer Y, Eksi F.
    J Int Med Res; 2015 Apr; 43(2):217-25. PubMed ID: 25547417
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of azithromycin in combination with amikacin, ceftazidime, ciprofloxacin or imipenem against clinical isolates of Acinobacter baumannii.
    Fernández-Cuenca F, Martínez-Martínez L, Pascual A, Perea EJ.
    Chemotherapy; 2003 May; 49(1-2):24-6. PubMed ID: 12714805
    [Abstract] [Full Text] [Related]

  • 20. In vitro activities of cellulase and ceftazidime, alone and in combination against Pseudomonas aeruginosa biofilms.
    Kamali E, Jamali A, Izanloo A, Ardebili A.
    BMC Microbiol; 2021 Dec 16; 21(1):347. PubMed ID: 34915848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.